Former Pfizer CEO and CFO flip on activist and say they now support company

Drew Armstrong

Executive Editor

Max Bayer

Pharma Reporter

In a late-night reversal, Pfizer’s former CEO and CFO issued a statement saying they now support the company’s existing management over activist investor Starboard Value …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Former Pfizer CEO and CFO flip on activist and say they now support company

Drew Armstrong

Executive Editor

Max Bayer

Pharma Reporter

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

‘Just the beginning’: Nobel Prizes show the AI era has arrived in biotech

GSK to pay up to $2.2B to settle almost all Zantac-related court cases

AI biotech insitro partners with Lilly on metabolic disease drugs

Exclusive Q&A: FDA's principal deputy commissioner on taking over for Califf, adcomms, accelerated approvals and more

CMS looks to $2 out-of-pocket cap for some commonly used generic drugs

Zealand Pharma hit with second CRL for glucagon receptor agonist

For­mer Pfiz­er CEO and CFO flip on ac­tivist and say they now sup­port com­pa­ny

Executive Editor

Pharma Reporter

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

Former Pfizer CEO and CFO flip on activist and say they now support company